
Tamara Lotan
Director of Research, Brady Urological Institute, Johns Hopkins · Stanford Health Care
Credentials: · · · ·
History
- Present
Brady Urological Institute Center · Stanford Health Care
- Present
- 2003–2007
Research
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
New England Journal of Medicine · 2014 · 2,287 citations
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 555 citations
Clinical implications of PTEN loss in prostate cancer
Review · Nature Reviews Urology · 2018 · Last of 7 authors · 518 citations

79 papers

41 papers

37 papers
- JE
35 papers

23 papers

22 papers

21 papers · 12 as a fellow

20 papers
Grants
- 2024–2029
2/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health
National Cancer Institute · U54
Project lead · $677.9K · Johns Hopkins University
- 2015–2026
Opportunities for Pathology Trainees in Cancer Research
National Cancer Institute · T32
Contact PI · $708.1K · Johns Hopkins University
- 2018–2024
National Cancer Institute · U19
Project lead · $1.7M · University of Southern California
- 2016–2022
Molecular and Cellular Mechanisms of Resistance to mTORC1 Inhibition in the Skin
National Cancer Institute · R01
Contact PI · $1.8M · Johns Hopkins University



